Wyatt Luenenborg

Wyatt Luenenborg has extensive work experience in the pharmaceutical and biotechnology industry. WYATT started their career in 2007 at Genentech, where they held various roles in marketing and sales. WYATT served as a Product Manager and Senior Product Manager, overseeing the marketing of Herceptin, Perjeta, and Kadcyla. Wyatt then became the Group Product Manager, Strategy, responsible for the marketing of Herceptin and Perjeta. WYATT later advanced to the position of Associate Director of BioOncology Commercial Pipeline, managing the company's commercial pipeline for cancer treatments. Wyatt then became the Director of Marketing for Erivedge, Cotellic, and Zelboraf, before being promoted to Director of National SKiN Cancer Sales for the same products. In 2019, they joined BeiGene as the Vice President of Marketing.

Wyatt Luenenborg holds a Bachelor of Science - BS degree in Soil Science and Agronomy, General from the University of Nebraska-Lincoln.